ZA895263B - Pharmaceutical composition for the prevention of sexually transmitted diseases - Google Patents

Pharmaceutical composition for the prevention of sexually transmitted diseases

Info

Publication number
ZA895263B
ZA895263B ZA895263A ZA895263A ZA895263B ZA 895263 B ZA895263 B ZA 895263B ZA 895263 A ZA895263 A ZA 895263A ZA 895263 A ZA895263 A ZA 895263A ZA 895263 B ZA895263 B ZA 895263B
Authority
ZA
South Africa
Prior art keywords
prevention
pharmaceutical composition
sexually transmitted
transmitted diseases
diseases
Prior art date
Application number
ZA895263A
Other languages
English (en)
Inventor
Jacques Julien Augros
Julien Augros Jacques
Original Assignee
Sspl Sa Safe Sex Prod Licens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sspl Sa Safe Sex Prod Licens filed Critical Sspl Sa Safe Sex Prod Licens
Publication of ZA895263B publication Critical patent/ZA895263B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
ZA895263A 1988-07-11 1989-07-11 Pharmaceutical composition for the prevention of sexually transmitted diseases ZA895263B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8809418 1988-07-11

Publications (1)

Publication Number Publication Date
ZA895263B true ZA895263B (en) 1991-03-27

Family

ID=9368330

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895263A ZA895263B (en) 1988-07-11 1989-07-11 Pharmaceutical composition for the prevention of sexually transmitted diseases

Country Status (38)

Country Link
US (1) US5439685A (fi)
EP (1) EP0351301B1 (fi)
JP (1) JPH0774164B2 (fi)
KR (1) KR0143231B1 (fi)
CN (1) CN1035038C (fi)
AP (1) AP108A (fi)
AR (1) AR243381A1 (fi)
AT (1) ATE97570T1 (fi)
BR (1) BR8903523A (fi)
CA (1) CA1341304C (fi)
CZ (1) CZ280722B6 (fi)
DD (1) DD283932A5 (fi)
DE (1) DE68910892T2 (fi)
DK (1) DK173527B1 (fi)
ES (1) ES2062065T3 (fi)
FI (1) FI101595B (fi)
HK (1) HK131095A (fi)
HU (1) HU206634B (fi)
IE (1) IE63115B1 (fi)
IL (1) IL90910A (fi)
LT (1) LT3754B (fi)
LV (1) LV10573B (fi)
MA (1) MA22036A1 (fi)
MD (1) MD406C2 (fi)
MX (1) MX170801B (fi)
MY (1) MY106242A (fi)
NO (1) NO178843C (fi)
NZ (1) NZ229891A (fi)
OA (1) OA09123A (fi)
PL (1) PL161848B1 (fi)
PT (1) PT91108B (fi)
RU (1) RU2065742C1 (fi)
SK (1) SK423889A3 (fi)
TN (1) TNSN89074A1 (fi)
TR (1) TR28353A (fi)
UA (1) UA26124A (fi)
YU (1) YU47899B (fi)
ZA (1) ZA895263B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02258718A (ja) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
US5693769A (en) * 1991-12-13 1997-12-02 Transcell Technologies, Inc. Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
US5795870A (en) * 1991-12-13 1998-08-18 Trustees Of Princeton University Compositions and methods for cell transformation
IT1255450B (it) * 1992-06-30 1995-10-31 Montefarmaco Spa Uso di acidi biliari come agenti antivirali
AU688344B2 (en) * 1993-07-19 1998-03-12 Mitsubishi-Tokyo Pharmaceuticals, Inc. Hepatitis C virus proliferation inhibitor
DE4341139C1 (de) * 1993-12-02 1995-04-13 Upmeyer Hans Juergen Dimeticon zur Behandlung von Aphthen
US5667492A (en) * 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US5700679A (en) * 1996-06-07 1997-12-23 Novavax, Inc. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
WO1998010744A1 (en) * 1996-09-12 1998-03-19 Simon Everard Barton Composition comprising an antiviral or antibacterial agent for preventing transmission of diseases
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US6211243B1 (en) 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
PL202918B1 (pl) * 2000-03-07 2009-08-31 Rush Presbyterian St Luke Przeciwbakteryjna i antykoncepcyjna kompozycja oraz jej zastosowanie
GB2415626B (en) * 2001-04-11 2006-03-08 Playtex Products Inc Use of a catamenial tampon which comprises a cationic surfactant for the treatment of vaginal malodor
GB2414394B (en) * 2001-04-11 2006-01-11 Playtex Products Inc Use of a catamenial tampon which comprises a non-ionic surfactant for the treatment of vaginal malodour
US8093446B2 (en) * 2001-04-11 2012-01-10 Playtex Products, Inc. Fibrous absorbent articles having malodor counteractant
ES2237732T3 (es) * 2003-11-03 2005-08-01 Peter-Hansen Volkmann Composicion para el cuidado vaginal.
CA2621066C (en) * 2005-08-29 2011-11-29 Sepsicure L.L.C. Method for treatment or prevention of conditions caused by gram-positive bacteria
DE102006020644A1 (de) * 2006-04-28 2007-10-31 Bayer Innovation Gmbh Antiseptikahaltige Silikonelastomere
US8409557B2 (en) 2006-09-28 2013-04-02 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US8062631B2 (en) 2006-09-28 2011-11-22 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
AU2012203566B1 (en) * 2008-03-27 2013-09-12 Clji I.P. Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
KR101130754B1 (ko) 2010-06-25 2012-03-28 제일약품주식회사 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물
BR112013011744B1 (pt) 2010-11-12 2021-04-27 The University Of Utah Research Foundation Dispositivo intravaginal para distribuição controlada de lubrificantes
BR112013026965B1 (pt) 2011-04-19 2019-04-02 ARMS Pharmaceutical LLC Método para inibir micro-organismos prejudiciais e composição formadora de barreira para os mesmos
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
CA2781379C (en) 2012-03-26 2013-09-03 Clji Ip Company, Llc Topical formulations for the prevention of sexually transmitted disease and methods of producing the same
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
KR102399883B1 (ko) * 2021-02-09 2022-05-20 재단법인대구경북과학기술원 압출용 복합고분자 펠릿 및 이의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1161484A (en) * 1965-08-20 1969-08-13 Mediline Ag Toilet Preparation
SE353658B (fi) * 1967-06-13 1973-02-12 Dow Corning
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US3770648A (en) * 1971-07-12 1973-11-06 Bristol Myers Co Anhydrous aerosol foam
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US4393871A (en) * 1977-06-27 1983-07-19 Vli Corporation Vaginal device
US4228797A (en) * 1978-09-25 1980-10-21 Dickey Richard P Intravaginal contraception method
ZA827582B (en) * 1981-11-06 1983-08-31 Ansell Inc Spermicidal condom
EP0081370A1 (en) * 1981-12-07 1983-06-15 Syntex (U.S.A.) Inc. Disposable intravaginal contraceptive devices releasing 1-substituted imidazoles
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
AU2272883A (en) * 1982-12-22 1984-06-28 Herpes Pharmaceutical Inc. Pharmaceutical compositions of steriods for treatment of herpes simplex infections
DE3346641A1 (de) * 1983-12-23 1985-07-04 Dynamit Nobel Ag, 5210 Troisdorf Silanmodifizierte estergemische
GB8402748D0 (en) * 1984-02-02 1984-03-07 Dunlop Ltd Intravaginal device
NL8600929A (nl) * 1986-04-11 1987-11-02 Fundatech Sa Werkwijze voor het vervaardigen van een gemedicateerd wegwerp-pessarium en gemedicateerd wegwerp-pessarium.
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
US4952411A (en) * 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
GB8706313D0 (en) * 1987-03-17 1987-04-23 Health Lab Service Board Treatment & prevention of viral infections
FR2614525B1 (fr) * 1987-04-29 1995-11-10 Jacques Augros Tampon en eponge elastique, notamment tampon vaginal
US4922928A (en) * 1988-08-17 1990-05-08 Michael Burnhill Vaginal device

Also Published As

Publication number Publication date
PL161848B1 (pl) 1993-08-31
EP0351301A2 (fr) 1990-01-17
DK340289A (da) 1990-01-12
PL280531A1 (en) 1990-05-28
EP0351301A3 (en) 1990-12-19
JPH02167235A (ja) 1990-06-27
MX170801B (es) 1993-09-14
LV10573B (en) 1995-08-20
IL90910A (en) 1994-12-29
JPH0774164B2 (ja) 1995-08-09
HK131095A (en) 1995-08-24
NO178843C (no) 1996-06-19
FI101595B1 (fi) 1998-07-31
FI893340A0 (fi) 1989-07-10
DK173527B1 (da) 2001-01-29
YU135789A (en) 1992-05-28
AU625716B2 (en) 1992-07-16
NO178843B (no) 1996-03-11
FI893340A (fi) 1990-01-12
AR243381A1 (es) 1993-08-31
PT91108B (pt) 1995-01-31
NO892826L (no) 1990-01-12
HU206634B (en) 1992-12-28
BR8903523A (pt) 1991-11-05
DD283932A5 (de) 1990-10-31
PT91108A (pt) 1990-02-08
OA09123A (fr) 1991-10-31
IE892218L (en) 1990-01-11
CN1035038C (zh) 1997-06-04
EP0351301B1 (fr) 1993-11-24
RU2065742C1 (ru) 1996-08-27
IE63115B1 (en) 1995-03-22
CZ280722B6 (cs) 1996-04-17
DE68910892T2 (de) 1994-05-05
HUT50445A (en) 1990-02-28
LV10573A (lv) 1995-04-20
SK278614B6 (en) 1997-11-05
YU47899B (sh) 1996-05-20
LTIP1660A (en) 1995-07-25
KR900001366A (ko) 1990-02-27
MA22036A1 (fr) 1991-10-01
TR28353A (tr) 1996-05-16
MY106242A (en) 1995-04-29
SK423889A3 (en) 1997-11-05
IL90910A0 (en) 1990-02-09
ATE97570T1 (de) 1993-12-15
LT3754B (en) 1996-03-25
FI101595B (fi) 1998-07-31
UA26124A (uk) 1999-06-07
ES2062065T3 (es) 1994-12-16
AP8900133A0 (en) 1989-10-31
CA1341304C (fr) 2001-10-09
NZ229891A (en) 1991-01-29
DK340289D0 (da) 1989-07-10
CN1041879A (zh) 1990-05-09
US5439685A (en) 1995-08-08
NO892826D0 (no) 1989-07-07
KR0143231B1 (ko) 1998-07-15
AU3802689A (en) 1990-01-11
CZ423889A3 (en) 1995-12-13
DE68910892D1 (de) 1994-01-05
TNSN89074A1 (fr) 1991-02-04
MD406C2 (ro) 1996-06-30
AP108A (en) 1991-02-23

Similar Documents

Publication Publication Date Title
NZ229891A (en) Pharmaceutical composition for the prevention of sexually transmitted diseases
HU896444D0 (en) Process for the preparation of pharmaceutical compositions
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
HU895444D0 (en) Process for the preparation of ophthalmic pharmaceutical composition
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
AU4530989A (en) Pharmaceutical composition for the treatment of cerebral edema
AU550675B2 (en) Pharmaceutical compositions for the treatment of skin
ZA82361B (en) Pharmaceutical composition for treating diseases of the oral cavity
IL87943A0 (en) Pharmaceutical compositions for piperidinoalkanol-decongestant combination
IL86753A0 (en) Pharmaceutical compositions for treatment of lupus
IL104132A0 (en) Compositions for the treatment of mammalian diseases
IL93242A0 (en) Pharmaceutical preparation for the treatment of tonsillitis
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
HU896636D0 (en) Process for the preparation of polyhydroxy-benzyloxypropanolamines and pharmaceutical compositions thereof
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
AU625716C (en) Pharmaceutical composition for the prevention of sexually transmitted diseases
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
ZA945651B (en) Use of benzenesulphonzlindole derivatives for the preparation of medicines
IL89431A0 (en) Pharmaceutical compositions for the treatment of autoimmune diseases
AU6975891A (en) Pharmaceutical compositions for the treatment of drug dependence
IE894219L (en) Pharmaceutical composition for the application of baclofen
HU895215D0 (en) Process for the preparation of pharmaceutical compositions against diseases caused by retrovirus
ZA906355B (en) Pharmaceutical compositions for the treatment of multiple sclerosis